Lipid Nanocapsules for the Oral Delivery of Fragile or Poorly Soluble CompoundsFriday, 12 April 2013 at 09:00 Add to Calendar ▼2013-04-12 09:00:002013-04-12 10:00:00Europe/LondonLipid Nanocapsules for the Oral Delivery of Fragile or Poorly Soluble CompoundsNanomedicine 2013 in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com Oral delivery is the first choice route of administration that allow a good compliance, safety and ambulatory therapy. Unfortunately the bioavailability of poorly soluble or fragile compounds is not good after oral administration. Lipid Nanocapsules (LNCs) while protecting the drug and enhancing its permeability across epithelial digestive barrier can be a solution to allow oral administration of first line therapies such as paclitaxel (lung and breast cancer) or fondaparinux (anticoagulant). The devellopement and characterisation of LNCs and their mechanisms of uptake across the intestinal barriers will be presented. |